Top Medical News
Roshini Claire Anthony, 2 hours ago

Patients with acute extremity pain experienced similar reductions in pain score regardless of whether they received a single dose of an opioid or nonopioid analgesic, a US study found.

Pearl Toh, 6 hours ago
An initial strategy of 1-year romosozumab followed by alendronate is superior over alendronate alone in reducing new vertebral fractures in postmenopausal women with osteoporosis at high risk for fracture, according to the ARCH* study.
Jairia Dela Cruz, 6 hours ago
Cyclosporine is as effective as infliximab in patients with steroid-refractory acute severe ulcerative colitis, having a similar colectomy rate but reduced incidence of serious adverse events, a study from Spain has shown.
Stephen Padilla, 7 hours ago
Diclofenac reduces the use of antibiotics in women with uncomplicated lower urinary tract infection (UTI) but remains less effective than norfloxacin for symptom relief of UTI, according to a recent study. In addition, diclofenac appears to be associated with an elevated risk of pyelonephritis.
Yesterday
Z-drugs carry an increased risk of fractures, which also suggest a potentially heightened risk of falls and injuries, in older adults, according to a systematic review and meta-analysis.
2 days ago
The launch of DCH Auriga marks the rebirth of LF Asia healthcare business. Starting November 2017, the healthcare business under LF Asia is rebranded to DCH Auriga Ltd., while the consumer goods distribution operations are transferred to Integrated Market Services Asia Ltd.
Roshini Claire Anthony, 3 days ago

Use of the blood infection biomarker procalcitonin as a guide to prescribing antibiotics led to lower antibiotic exposure and side effects, as well as a lower mortality rate in individuals with acute respiratory infections, based on findings of a meta-analysis.

Special Reports
01 Nov 2017
Since the beginning of the probiotic era in the 20th century, much emphasis has been given on its role in the regulation of gut health. The past decades have seen increasing evidence on the benefits of probiotics beyond just gut health, to even encompass, skin health, memory and brain health, and immunity.
01 Sep 2017
Complementary medicines can play an important part in maintaining wellness, preventing deficiencies and optimizing health outcomes, says Dr Lesley Braun PhD, Director of the Blackmores Institute. 
Dr. Yeo Khung Keong, Dr. Wiwun Tungsubutra, Prof. Peter Collins, 31 Aug 2017
Agents such as beta-blockers and calcium antagonists have been the cornerstone of treatment for stable angina for some time. However, new options are emerging for patients who remain inadequately controlled on conventional therapies. At a recent Menarini-sponsored symposium held during the APSC Congress 2017 in Singapore, three experts discussed the current treatment landscape, as well as changing paradigms and new effective options for patients with symptomatic angina.
01 Aug 2017
Complementary medicines are popular among consumers in Malaysia so it is important for pharmacists to be well versed in complementary medicines.
Prof. Peter Collins, Prof. Giuseppe Mancia, Prof. Carolyn Lam, Dr. Choo Gim Hooi, 12 Jul 2017
Coronary artery disease (CAD) is the leading cause of death worldwide and is expected to remain so for the foreseeable future due to both the ageing population and the increasing prevalence of risk factors such as hypertension, dyslipidaemia, and diabetes. CAD is also the primary risk factor in the development of heart failure (HF). At the 2nd Asia Pacific CardioConnect Meeting in Hong Kong sponsored by Menarini, a group of international and regional experts discussed current strategies for managing stable CAD and HF and highlighted areas where patient outcomes may be improved.
12 Jul 2017
DUKORAL – Inactivated Vibrio cholerae O1 serogroup & recombinant cholera toxin B subunit (WC/rCTB) vaccine (oral) – AJ Biologics
01 Jul 2017
At the recent launch of Nurofen® Express by Reckitt Benckiser Malaysia, Ms Joyce McSwan spoke on the importance of managing tension-type headache (TTH), highlighting the roles of drug and non-drug approaches in improving treatment outcomes.
Conference Reports
Pearl Toh, 16 Nov 2017
Using bioabsorbable polymer drug-eluting stents (DES) with a shorter duration of double antiplatelet therapy (DAPT) in elderly patients undergoing percutaneous coronary intervention (PCI) leads to fewer adverse events than bare-metal stents (BMS) without increasing bleeding risk, according to the SENIOR* trial presented at TCT 2017 Congress.
Pearl Toh, 21 Oct 2017
Bisphosphonate is one of the first-line therapy for treating osteoporosis, but its long-term use should take into account the balance between its antifracture benefit and risk of adverse events such as atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), according to a presentation at the AFOS 2017 Meeting in Kuala Lumpur, Malaysia.
Roshini Claire Anthony, 19 Oct 2017

Increasing evidence points to a link between hypertension and cognitive decline, particularly in the elderly population, according to a presentation at APCH 2017. However, the impact of antihypertensive medication use on dementia incidence is unestablished. 

Elvira Manzano, 17 Oct 2017
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
17 Oct 2017
Slideshow: Highlights from the Asian Federation of Osteoporosis Societies (AFOS 2017) 5th Annual Scientific Meeting
Roshini Claire Anthony, 16 Oct 2017

Treatment failure in osteoporosis remains a problem, even among patients who are treatment-adherent, according to a presentation at the recent meeting of the Asian Federation of Osteoporosis Societies (AFOS 2017), held in Kuala Lumpur, Malaysia. 

Audrey Abella, 16 Oct 2017
The use of angiotensin converting enzyme (ACE) inhibitors may prevent repeat revascularization in patients who underwent percutaneous transluminal angioplasty (PTA) for peripheral artery disease (PAD) compared with angiotensin receptor blockers (ARB), according to a presentation at APCH 2017.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD